A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(18 sites)

United States

Hs0006 50175, Phoenix, Arizona

Hs0006 50708, Roseville, California

Hs0006 50684, Sacramento, California

Hs0006 50707, Washington D.C., District of Columbia

Hs0006 50199, Miami, Florida